TISANNA LIMITED

Financial Health Score: A- (Excellent with minor symptoms of illiquidity)

TISANNA LIMITED presents a robust constitution, underpinned by a strong asset base and consistent equity growth over the last decade. However, the company is currently suffering from a mild case of "anemia"—its cash reserves are severely depleted relative to its size, and its circulatory system (cash flow) is under pressure from high debtors and generous related-party distributions.

1. Key Vital Signs

• Body Mass & Muscle (Net Assets & Equity): £10.59 million
  • Interpretation: The patient is in excellent physical condition. Net assets have grown steadily from £3.12 million in 2016 to £10.59 million in 2025. This demonstrates a strong capacity to generate and retain wealth over the long term.
• Blood Pressure (Leverage): Total Liabilities (£13.08M) vs Total Assets (£23.68M)
  • Interpretation: Blood pressure is within a healthy range for a property business. The company is asset-heavy, with secured debts (£5.28M) comfortably covered by the investment property portfolio (£12.99M). The patient is not over-indebted, but the debt is secured against its vital organs (properties).
• Pulse & Circulation (Cash Position): £73,022
  • Interpretation: The pulse is dangerously weak. Cash has plummeted from £535,904 in 2024 and £1.66 million in 2020 to just £73k. For a company with over £23 million in assets, this leaves the patient with virtually no immediate reserves to fight off a sudden financial shock.
• Cholesterol/Blockages (Current Debtors): £10.61 million
  • Interpretation: There is a significant blockage in the arteries. The vast majority of the company's current assets are tied up in "Other Debtors" (£8.65M) and "Joint Ventures" (£1.97M). While this money is technically owed to the company, it is not currently flowing through the system.
• Metabolism (Profitability): Profit for the year £239,920
  • Interpretation: The metabolism is functioning, but the energy generated is being redirected. The company made a healthy profit, but it paid out £160,000 in dividends and £178,100 in Gift Aid to a related charitable company (Chasehawk Limited), totaling £338,100—more than the profit it generated for the year.

2. Diagnosis

Asset-Rich, Cash-Poor Syndrome with Related-Party Strain

The financial data reveals a company that is fundamentally healthy on paper but is experiencing poor circulation.

The underlying business—property development and letting—is strong. The portfolio has grown substantially, and the company holds over £10.5 million in equity. However, the clinical presentation shows a business that is "property rich but cash poor." The severe drop in cash reserves is a symptom of two underlying issues:

1. Arterial Blockage: The company is sitting on over £10.6 million of debtors. Until these funds are collected, the business is operating with a dangerously thin cash buffer. If a major debtor defaults, the patient could go into cardiac arrest (insolvency) despite having substantial overall wealth.
2. Excessive Blood Donation: The company is donating more blood than it produces. The profit for the year was £239,920, but distributions (dividends and Gift Aid to the directors' related charity, Chasehawk Limited) totaled £338,100. Additionally, the company has advanced an interest-free loan of £117,010 to Chasehawk Limited. This generous financial philanthropy is asphyxiating the company's own cash flow.

Furthermore, the investment property valuation saw a slight reduction due to disposals (£438,404), meaning the company is slowly liquidating its core assets to fund operations and distributions.

3. Recommendations

To restore full financial vitality and ensure long-term wellness, the following treatment plan is prescribed:

1. Improve Circulation (Debt Collection): Urgently address the £10.6 million in debtors. Management must ensure these amounts are collectible and set a timeline for conversion to cash. If these are long-term development loans or inter-company balances, they should be reclassified to reflect their true liquidity profile accurately.
2. Oxygen Therapy (Cash Reserves): Halt or significantly reduce cash outflows until the cash pulse strengthens to at least 5-10% of total assets (approx. £1M - £2.4M). The current £73k is insufficient to cover even a minor operational emergency.
3. Review Philanthropic Distributions: While supporting a related charity (Chasehawk Limited) is commendable, the current rate of Gift Aid and interest-free loans is draining the parent company's lifeblood. Distributions should be strictly limited to actual realized profits, and interest-free loans should be formalized or called in to boost cash.
4. Monitor Secured Debts: The £5.28 million in secured bank loans represents a significant ongoing financial commitment. Ensure that property valuations remain robust enough to support this leverage, particularly as interest rates fluctuate.